Because the protein products of many of the inflammatory genes of which the C/EBPs have been shown to regulate in the periphery [5], [6], [13] are also known to be altered in AD [1], our goal is determining which C/EBP isoforms are expressed in human brain and which are upregulated in pathologically-vulnerable regions of the AD brain. This evidence concerns the gene CEBPA and Alzheimer disease.